New Salmonella Multiplex PCR Solution offers First Validated Assay for Simultaneous Detection of Three Salmonella Targets in One Rapid Test

New Salmonella Multiplex PCR Solution offers First Validated Assay for Simultaneous Detection of Three Salmonella Targets in One Rapid Test Real-Time PCR workflow gains AOAC-RI approval for rapid and simultaneous detection of Salmonella species, Salmonella Typhimurium and Salmonella Enteritidis BASINGSTOKE, England, Dec. 5, 2017 /PRNewswire/ — Poultry and pork producers can now rapidly screen for... Read more

Danaher Announces Leadership Appointment

WASHINGTON, Nov. 28, 2017 /PRNewswire/ — Danaher Corporation (NYSE: DHR) announced today that its Board of Directors is appointing Joakim Weidemanis to the position of Executive Vice President of Danaher Corporation, with responsibility for the Company’s Product Identification and Water Quality platforms. With this appointment, Mr. Weidemanis will become an Executive Officer of the Company.... Read more

The latest generation Fossomatic™ 7 analyser for testing somatic cell count in raw milk is now approved by Microval in Europe, certificate number: 2016LR62.

21. Nov, 2017 The new approval builds on approvals for the earlier generation Fossomatic™ FC that was the first instrument in the world approved by both Microval in Europe and NCIMS/ FDA in the USA. Microval is a European certification organization for the validation and approval of alternative methods for the microbiological analysis of food... Read more

Illumina Wins Infringement Suit Against Premaitha Health plc and Ariosa Diagnostics, Inc.

SAN DIEGO–(BUSINESS WIRE)–Illumina, Inc. (NASDAQ: ILMN) announced today that the High Court of Justice, Chancery Division, Patents Court in the United Kingdom issued a judgment in its favor in the patent infringement suit filed against Premaitha Health plc, et al. and the patent infringement suit filed against Ariosa Diagnostics, Inc., et al. The Court found... Read more

Exclusive Global License for New Method of iPS Cell Production Obtained

Kusatsu/Shiga, Japan — October 19, 2017 — Takara Bio Inc. (Takara Bio), today announced the conclusion of a license agreement with Kyushu University for a new iPS cell production technology owned by Kyushu University, using the measles virus vector, a novel gene transfer vector, under which Takara Bio is granted an exclusive global license. Takara... Read more

Brooks Automation Announces Participation in the Sixth Annual New York City Investor Summit

CHELMSFORD, Mass., Nov. 21, 2017 (GLOBE NEWSWIRE) — Brooks Automation, Inc. (Nasdaq:BRKS) announced today that Steve Schwartz, President and Chief Executive Officer, and Lindon Robertson, Executive Vice President and Chief Financial Officer, will participate in the 6th Annual New York City Investor Summit to be held December 6, 2017 at Le Parker Méridien Hotel, New... Read more

Smiths Detection IONSCAN 600 First ‘Approved’ Explosives Trace Detector on New TSA Air Cargo Screening List

16 Nov 2017  Print this page Smiths Detection IONSCAN 600 First ‘Approved’ Explosives Trace Detector on New TSA Air Cargo Screening List Edgewood, MD –  Smiths Detection’s IONSCAN 600 is the first explosives trace detection system to be ‘Approved’ on the TSA Air Cargo Screening Technology List (ACSTL) under the latest program requirements to ensure... Read more

Oxford Genetics Licenses SnapFast Expression Vectors to Twist Bioscience

Download PDF November 16, 2017, Oxford, England and San Francisco, Calif. – Oxford Genetics, a leader in innovative synthetic biology-based technologies for biologics discovery, development and delivery, announced today a new licensing agreement with Twist Bioscience Corporation, a company enabling customers to succeed through its offering of rapid, high-quality synthetic DNA. Oxford Genetics will supply Twist... Read more

Xona Microfluidics, LLC Issued European Patents for Neuron Research Device

November 16, 2017 8:12 A.M. Eastern Time RESEARCH TRIANGLE PARK, DURHAM, NC—(BUSINESS WIRE)—Xona Microfluidics, LLC, a biotechnology company focused on manufacturing and distributing microfluidic devices to neuroscientists and laboratories worldwide, today announced that the European Patent Office has issued EPO Patent Nos. 1581612 and 2719756 covering the design of Xona’s products used for neuroscientific and... Read more

Luminex Corporation To Present At The 29th Annual Piper Jaffray Healthcare Conference

AUSTIN, Texas, Nov. 14, 2017 /PRNewswire/ — Luminex Corporation (Nasdaq: LMNX) today announced that management will present at the 29th Annual Piper Jaffray Healthcare Conference to be held November 28 -29, 2017, in New York. The investor presentation will begin at 8:00 a.m. Eastern time on Wednesday, November 29, 2017.  The presentation will be webcast live... Read more